These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 24705305

  • 1. Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma.
    Wang L, Fu D, Qiu Y, Xing X, Xu F, Han C, Xu X, Wei Z, Zhang Z, Ge J, Cheng W, Xie HL.
    Cancer Lett; 2014 Jul 10; 349(1):77-86. PubMed ID: 24705305
    [Abstract] [Full Text] [Related]

  • 2. Identification of differentially expressed long noncoding RNAs in bladder cancer.
    Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon A, Chen W, Catto JW.
    Clin Cancer Res; 2014 Oct 15; 20(20):5311-21. PubMed ID: 25165097
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA.
    Eur Urol; 2014 Jun 15; 65(6):1140-51. PubMed ID: 24373479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer.
    Xue Y, Ma G, Zhang Z, Hua Q, Chu H, Tong N, Yuan L, Qin C, Yin C, Zhang Z, Wang M.
    Oncotarget; 2015 Jan 01; 6(1):484-93. PubMed ID: 25514464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
    Pei L, Yan D, He Q, Kong J, Yang M, Ruan H, Lin Q, Huang L, Huang J, Lin T, Qin H.
    Cell Oncol (Dordr); 2023 Oct 01; 46(5):1509-1527. PubMed ID: 37355516
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec 01; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.
    Lan X, Zhang H, Wang Z, Dong W, Sun W, Shao L, Zhang T, Zhang D.
    Gene; 2015 Sep 10; 569(1):109-17. PubMed ID: 26003293
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SOX4 expression levels in urothelial bladder carcinoma.
    Gunes S, Yegin Z, Sullu Y, Buyukalpelli R, Bagci H.
    Pathol Res Pract; 2011 Jul 15; 207(7):423-7. PubMed ID: 21680105
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
    Cao YP, Zhou J, Li WJ, Shao Y, Zheng SY, Tian T, Xie KP, Yan X.
    Cell Physiol Biochem; 2018 Jul 15; 50(3):1154-1163. PubMed ID: 30355928
    [Abstract] [Full Text] [Related]

  • 20. Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endometrial carcinoma.
    Zhai W, Li X, Wu S, Zhang Y, Pang H, Chen W.
    Int J Oncol; 2015 May 15; 46(5):2125-37. PubMed ID: 25695231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.